The limited number of studies examining the impact of exercise on CX3CL1 levels, along with conflicting findings in both PD and exercise research, highlights the need for further investigation to determine the utility of CX3CL1 as a biomarker of inflammation in exercise interventions in PD. The gene discussed is CX3CL1; the disease is Parkinson disease.